XLV — Health Care
Pharmaceuticals, biotech, and hospitals. Defensive characteristics with long-term growth.
$10,000 invested in 1999$67,678by 2024
CAGR
+7.6%
26-year annualized
Total Return
577%
$10k → $67,678
Max Drawdown
-27.2%
worst peak-to-trough
Best Year
+41%
2013
Growth of $10,000
1999–2024Annual returns — XLV (1999–2024)
1999-5%
2000+28%
2001-12%
2002-18%
2003+17%
2004+2%
2005+8%
2006+7%
2007+7%
2008-23%
2009+19%
2010+3%
2011+10%
2012+17%
2013+41%
2014+25%
2015+7%
2016-3%
2017+22%
2018+7%
2019+21%
2020+13%
2021+26%
2022-2%
2023+2%
2024+3%
Year-by-year performance
| Year | Return | Portfolio Value |
|---|---|---|
| 2024 | +2.60% | $67,678 |
| 2023 | +2.10% | $65,963 |
| 2022 | -2.10% | $64,606 |
| 2021 | +26.10% | $65,992 |
| 2020 | +13.40% | $52,333 |
| 2019 | +20.80% | $46,149 |
| 2018 | +6.50% | $38,203 |
| 2017 | +22.10% | $35,871 |
| 2016 | -2.70% | $29,379 |
| 2015 | +6.90% | $30,194 |
| 2014 | +25.30% | $28,245 |
| 2013 | +41.40% | $22,542 |
| 2012 | +17.40% | $15,942 |
| 2011 | +10.20% | $13,579 |
| 2010 | +3.20% | $12,322 |
| 2009 | +19.00% | $11,940 |
| 2008 | -22.80% | $10,034 |
| 2007 | +7.30% | $12,997 |
| 2006 | +6.60% | $12,113 |
| 2005 | +7.60% | $11,363 |
| 2004 | +1.60% | $10,560 |
| 2003 | +17.00% | $10,394 |
| 2002 | -17.70% | $8,884 |
| 2001 | -11.60% | $10,794 |
| 2000 | +28.40% | $12,211 |
| 1999 | -4.90% | $9,510 |
All returns are total returns (price appreciation + dividends reinvested). Expense ratio of 0.09% not deducted.
Compare XLV against other ETFs
Other Sectors ETFs
Build your portfolio
Mix XLV with other ETFs and backtest the result
Add XLV to a custom portfolio with up to 4 other ETFs and see how your specific allocation would have performed over time.
Open Portfolio Builder →Past performance does not guarantee future results.